The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy
Authors
Keywords
Neurons, Entorhinal cortex, Dentate gyrus, Synapses, Alzheimers disease, Autophagic cell death, Zinc staining, Microglial cells
Journal
PLoS One
Volume 10, Issue 11, Pages e0142340
Publisher
Public Library of Science (PLoS)
Online
2015-11-06
DOI
10.1371/journal.pone.0142340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old
- (2014) John L. Robinson et al. BRAIN
- Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature
- (2014) A. Caccamo et al. JOURNAL OF NEUROSCIENCE
- Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance
- (2014) Teng Jiang et al. NEUROPHARMACOLOGY
- Microglial diversity by responses and responders
- (2014) Ulla Gertig et al. Frontiers in Cellular Neuroscience
- A Rapid Gene Delivery-Based Mouse Model for Early-Stage Alzheimer Disease-Type Tauopathy
- (2013) Robert Siman et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
- (2013) Mathias Jucker et al. NATURE
- Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
- (2013) Sefika Ozcelik et al. PLoS One
- Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage
- (2012) Maria Teresa Viscomi et al. Autophagy
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
- (2012) Erin E. Congdon et al. Autophagy
- Tau oligomers and tau toxicity in neurodegenerative disease
- (2012) Sarah M. Ward et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
- (2012) Véronique Schaeffer et al. BRAIN
- Direct Evidence for Domain-Sensitive Functional Subregions in Human Entorhinal Cortex
- (2012) H. Schultz et al. JOURNAL OF NEUROSCIENCE
- Rapamycin Delays Disease Onset and Prevents PrP Plaque Deposition in a Mouse Model of Gerstmann-Straussler-Scheinker Disease
- (2012) C. J. Cortes et al. JOURNAL OF NEUROSCIENCE
- Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
- (2012) Alix de Calignon et al. NEURON
- Trans-Synaptic Spread of Tau Pathology In Vivo
- (2012) Li Liu et al. PLoS One
- Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43
- (2012) I.-F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fighting neurodegeneration with rapamycin: mechanistic insights
- (2011) Jordi Bové et al. NATURE REVIEWS NEUROSCIENCE
- Autophagy failure in Alzheimer's disease—locating the primary defect
- (2011) Ralph A. Nixon et al. NEUROBIOLOGY OF DISEASE
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Probing the Biology of Alzheimer's Disease in Mice
- (2010) Karen H. Ashe et al. NEURON
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3
- (2009) Fiona M. Menzies et al. BRAIN
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
- (2008) L. Meikle et al. JOURNAL OF NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now